Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

Summary: The economic burden caused by treatment failures of migraine was explored in a study led by Dr. Lujia Zhou, KMK Consulting, Inc. The study results, published in The Journal of Neurology, “Economic Burden Increased with Number of Treatment Failures in Migraine Patients -A Retrospective Claims Database Analysis in the United States (1485),”demonstrated clearly that […]

KMK Welcomes Oncology Market Research Veteran Lisa Logan

Lisa Logan has joined the team at KMK Consulting as Associate Principal for their Market Research division, with a focus in Oncology. KMK Consulting is pleased to announce the appointment of Lisa Logan as Associate Principal of their Market Research division. In this role Lisa will support the growing market research team and expand KMK’s oncology capabilities. […]

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

MORRISTOWN, N.J., March 18, 2020 /PRNewswire/ — In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, GSK was ranked as the top company delivering superior customer value and sales force engagement, as well as delivering therapeutic innovation in the asthma market according to pulmonary disease specialists. The research was conducted in February 2020, […]

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Morristown, N.J., March 26, 2020 /PRNewswire/ — In an ongoing series of research conducted by KMK Consulting, Inc. covering Innovation & Customer Value, Allergan and Bausch Health (backed by its Salix division) were ranked as the top companies best poised to deliver therapeutic innovation in the IBS market. The research was conducted in February 2020 among 250 gastroenterologists, using KMK’s […]